Hummus for Health: Dietary Quality and Health Outcomes in Toddlers
NCT02696278 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139
Last updated 2017-07-17
Summary
The goal of this study is to examine the effect of increasing children's intake of fiber and unsaturated fat, through daily servings of hummus and vegetables, on their microbiome profile.
Conditions
Interventions
- OTHER
-
Lesson about vegetables
During the introductory period, children will receive a lesson about vegetables 3 days a week for 3 weeks.
- OTHER
-
Vegetables
During the introductory period, children will be served vegetables 3 days a week for 3 weeks during snack time at their daycare center. During the intervention period, children will receive vegetables everyday for 3 weeks during snack time at their daycare center.
- OTHER
-
Hummus
During the introductory period, children will be served hummus, depending on their group assignment, 3 days a week for 3 weeks during snack time at their daycare center. During the intervention period, children will receive hummus, depending on their group assignment, everyday for 3 weeks during snack time at their daycare center.
Sponsors & Collaborators
-
Sabra Dipping Company, LLC
collaborator OTHER -
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Sheryl O Hughes, PhD · Baylor College of Medicine
-
Alexis Frazier-Wood, PhD · Baylor College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Months
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-06-30
Countries
- United States
Study Locations
More Related Trials
-
The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants
NCT01807858 ·Status: UNKNOWN ·Phase: NA
-
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
NCT02632266 ·Status: COMPLETED ·Phase: PHASE4
-
Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country
NCT02246010 ·Status: TERMINATED ·Phase: NA
-
Effects of HMOs on the Faecal Microbiota and on Host Metabolism in Obese Children
NCT02786160 ·Status: COMPLETED ·Phase: NA
-
Effects of Complementary Feeding on Infant Growth and Gut Health
NCT05012930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Salmon in Pregnancy Study
NCT00801502 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas
NCT04059666 ·Status: TERMINATED ·Phase: NA
-
Infant Formula and Toddler Drink Feeding Intervention
NCT04495738 ·Status: TERMINATED ·Phase: NA
-
Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
NCT00005888 ·Status: COMPLETED ·Phase: NA
-
Maternal High Fibre Fermented Diet Effect on Breastfed Infant Gut Microbiome
NCT06977113 ·Status: RECRUITING ·Phase: NA
-
Pasteurization of Mother's Own Milk for Preterm Infants
NCT01580826 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
NCT03266913 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
NCT00418821 ·Status: TERMINATED ·Phase: PHASE4
-
Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?
NCT05075031 ·Status: UNKNOWN
-
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
NCT01137877 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants
NCT01411761 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
NCT01413581 ·Status: TERMINATED ·Phase: PHASE3
-
HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants
NCT06631937 ·Status: RECRUITING ·Phase: NA
-
Fiber Use in Pediatric Short Bowel Syndrome
NCT00922805 ·Status: WITHDRAWN ·Phase: NA
-
Acceptability and Tolerance Study of an Amino Acid Formula with HMOs
NCT04575298 ·Status: TERMINATED
-
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
NCT01279265 ·Status: COMPLETED ·Phase: NA
-
Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
NCT03477669 ·Status: TERMINATED ·Phase: NA
-
Baylor Infant Biomarker of Nutrition Study
NCT03996395 ·Status: TERMINATED
-
Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying
NCT01956682 ·Status: COMPLETED ·Phase: PHASE4
-
Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties
NCT00859092 ·Status: COMPLETED ·Phase: PHASE2